Department of Clinical Science and Education, Karolinska Institute, Soder Hospital, Stockholm, Sweden.
J Matern Fetal Neonatal Med. 2022 Dec;35(25):7306-7311. doi: 10.1080/14767058.2021.1946790. Epub 2021 Nov 10.
Even today, hundreds of thousands of women die or suffer high levels of morbidity associated with childbirth. One of the most common causes is halted labor progress, or labor dystocia. There have been no developments in the diagnosis or treatment of dystocic deliveries since Friedman designed the Partogram in the 1950s. Oxytocin is the only treatment for dystocic labor. Sometimes, oxytocin is a lifesaver for the woman, especially in severe postpartum hemorrhages. At the same time, it is also one of the most overused drugs in obstetric care. This review article is meant to provide a short overview of the current knowledge of uterine metabolism during labor, uterine lactate production, and its association with labor dystocia. The article also intends to reflect new ways of thinking regarding practical recommendations for treating labor dystocia and offer a look at the future of dystocic labor management.
即使在今天，仍有成千上万的女性死于分娩相关的高发病率，或因分娩并发症而遭受严重的健康问题。其中最常见的原因之一是产程停滞，也就是难产。自弗里德曼（Friedman）在 20 世纪 50 年代设计产程图以来，难产的诊断和治疗方法没有任何进展。催产素是治疗难产的唯一方法。有时，催产素是女性的救命稻草，尤其是在严重的产后出血情况下。同时，它也是产科护理中最滥用的药物之一。本文旨在提供分娩时子宫代谢、子宫乳酸生成及其与难产关系的最新知识的简要概述。文章还试图反映治疗难产的实际建议的新思维方式，并展望难产管理的未来。
